Concepts (324)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin D | 25 | 2018 | 184 | 3.530 |
Why?
|
| Vitamin D Deficiency | 17 | 2018 | 89 | 2.670 |
Why?
|
| Obesity | 29 | 2020 | 1175 | 2.320 |
Why?
|
| Aging | 26 | 2020 | 946 | 2.290 |
Why?
|
| Body Composition | 19 | 2020 | 397 | 1.860 |
Why?
|
| Weight Loss | 14 | 2020 | 480 | 1.830 |
Why?
|
| Mobility Limitation | 7 | 2017 | 219 | 1.480 |
Why?
|
| Aged | 76 | 2020 | 10301 | 1.400 |
Why?
|
| Dietary Proteins | 8 | 2020 | 55 | 1.270 |
Why?
|
| Overweight | 6 | 2018 | 280 | 1.240 |
Why?
|
| Life Style | 8 | 2020 | 408 | 1.240 |
Why?
|
| Body Mass Index | 24 | 2019 | 923 | 1.200 |
Why?
|
| European Continental Ancestry Group | 26 | 2018 | 1166 | 1.160 |
Why?
|
| Physical Fitness | 5 | 2012 | 131 | 1.150 |
Why?
|
| Exercise | 7 | 2019 | 672 | 1.140 |
Why?
|
| Polymorphism, Single Nucleotide | 21 | 2018 | 1062 | 1.110 |
Why?
|
| Female | 81 | 2020 | 19959 | 1.060 |
Why?
|
| Male | 78 | 2020 | 19165 | 1.060 |
Why?
|
| Caloric Restriction | 4 | 2019 | 106 | 1.040 |
Why?
|
| Diet | 7 | 2020 | 391 | 1.020 |
Why?
|
| Humans | 93 | 2020 | 32005 | 0.920 |
Why?
|
| Prospective Studies | 25 | 2020 | 2282 | 0.840 |
Why?
|
| Independent Living | 5 | 2020 | 99 | 0.800 |
Why?
|
| Eating | 3 | 2017 | 74 | 0.790 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2018 | 1428 | 0.780 |
Why?
|
| Accidental Falls | 4 | 2019 | 222 | 0.770 |
Why?
|
| Muscle Strength | 7 | 2020 | 161 | 0.760 |
Why?
|
| Longevity | 1 | 2020 | 24 | 0.720 |
Why?
|
| Motor Activity | 6 | 2015 | 325 | 0.720 |
Why?
|
| Genome-Wide Association Study | 15 | 2018 | 547 | 0.710 |
Why?
|
| Parathyroid Hormone | 5 | 2012 | 45 | 0.690 |
Why?
|
| Dietary Supplements | 6 | 2018 | 185 | 0.660 |
Why?
|
| African Continental Ancestry Group | 10 | 2018 | 363 | 0.650 |
Why?
|
| Disabled Persons | 2 | 2012 | 105 | 0.630 |
Why?
|
| Pennsylvania | 8 | 2018 | 83 | 0.590 |
Why?
|
| Tennessee | 8 | 2018 | 102 | 0.590 |
Why?
|
| Amino Acids | 1 | 2017 | 46 | 0.560 |
Why?
|
| Body Weight | 7 | 2020 | 310 | 0.560 |
Why?
|
| Middle Aged | 31 | 2020 | 11817 | 0.550 |
Why?
|
| Vitamins | 3 | 2015 | 68 | 0.550 |
Why?
|
| Nutrition Policy | 3 | 2020 | 35 | 0.540 |
Why?
|
| Follow-Up Studies | 14 | 2019 | 2265 | 0.540 |
Why?
|
| Muscle, Skeletal | 7 | 2019 | 519 | 0.530 |
Why?
|
| Homebound Persons | 1 | 2015 | 9 | 0.520 |
Why?
|
| Cholecalciferol | 1 | 2015 | 21 | 0.510 |
Why?
|
| Food Services | 1 | 2015 | 20 | 0.510 |
Why?
|
| Cohort Studies | 19 | 2018 | 1817 | 0.490 |
Why?
|
| Behavior Therapy | 1 | 2014 | 103 | 0.460 |
Why?
|
| Health Status | 8 | 2018 | 399 | 0.450 |
Why?
|
| Blood Glucose | 7 | 2019 | 494 | 0.440 |
Why?
|
| Activities of Daily Living | 5 | 2014 | 257 | 0.430 |
Why?
|
| Aged, 80 and over | 15 | 2020 | 3990 | 0.420 |
Why?
|
| Feeding Behavior | 4 | 2017 | 161 | 0.420 |
Why?
|
| African Americans | 9 | 2018 | 1425 | 0.420 |
Why?
|
| Genetic Loci | 6 | 2018 | 146 | 0.410 |
Why?
|
| Dairy Products | 2 | 2017 | 13 | 0.400 |
Why?
|
| Proportional Hazards Models | 7 | 2014 | 753 | 0.400 |
Why?
|
| Cross-Sectional Studies | 12 | 2018 | 1531 | 0.400 |
Why?
|
| Risk Factors | 18 | 2019 | 3876 | 0.400 |
Why?
|
| Incidence | 11 | 2019 | 1199 | 0.400 |
Why?
|
| Geriatric Assessment | 9 | 2019 | 390 | 0.380 |
Why?
|
| Nutritional Status | 4 | 2014 | 75 | 0.380 |
Why?
|
| Depression | 1 | 2014 | 444 | 0.380 |
Why?
|
| Hand Strength | 4 | 2018 | 101 | 0.370 |
Why?
|
| Insulin | 4 | 2015 | 367 | 0.370 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2019 | 510 | 0.360 |
Why?
|
| Energy Intake | 7 | 2019 | 128 | 0.350 |
Why?
|
| Mortality | 4 | 2015 | 125 | 0.340 |
Why?
|
| Diet, Reducing | 4 | 2019 | 106 | 0.340 |
Why?
|
| Diet Surveys | 5 | 2019 | 57 | 0.340 |
Why?
|
| United States | 16 | 2019 | 3939 | 0.330 |
Why?
|
| Sarcopenia | 3 | 2019 | 64 | 0.320 |
Why?
|
| Retirement | 1 | 2008 | 12 | 0.320 |
Why?
|
| Linear Models | 7 | 2018 | 447 | 0.300 |
Why?
|
| Bone Density | 2 | 2019 | 205 | 0.290 |
Why?
|
| Muscular Atrophy | 1 | 2008 | 71 | 0.290 |
Why?
|
| Cognition | 4 | 2016 | 555 | 0.290 |
Why?
|
| Diabetes Mellitus | 2 | 2008 | 411 | 0.290 |
Why?
|
| Heart Diseases | 2 | 2018 | 116 | 0.290 |
Why?
|
| Longitudinal Studies | 7 | 2018 | 767 | 0.280 |
Why?
|
| Nutrition Assessment | 4 | 2011 | 55 | 0.280 |
Why?
|
| Genotype | 8 | 2018 | 733 | 0.280 |
Why?
|
| Gait | 3 | 2013 | 142 | 0.270 |
Why?
|
| Vegetables | 2 | 2010 | 35 | 0.270 |
Why?
|
| Fruit | 2 | 2010 | 53 | 0.270 |
Why?
|
| Adult | 16 | 2018 | 9345 | 0.260 |
Why?
|
| Pilot Projects | 2 | 2019 | 545 | 0.260 |
Why?
|
| Ethnic Groups | 3 | 2017 | 476 | 0.250 |
Why?
|
| Proteins | 3 | 2020 | 144 | 0.250 |
Why?
|
| Sex Factors | 7 | 2020 | 663 | 0.250 |
Why?
|
| Lung | 2 | 2018 | 249 | 0.240 |
Why?
|
| Thinness | 2 | 2015 | 33 | 0.220 |
Why?
|
| Confidence Intervals | 3 | 2009 | 149 | 0.220 |
Why?
|
| Diet, Mediterranean | 2 | 2014 | 31 | 0.220 |
Why?
|
| Alleles | 5 | 2014 | 248 | 0.210 |
Why?
|
| Meat | 2 | 2015 | 15 | 0.210 |
Why?
|
| Cognition Disorders | 3 | 2014 | 385 | 0.210 |
Why?
|
| Osteoporosis | 2 | 2019 | 70 | 0.200 |
Why?
|
| Adipose Tissue | 3 | 2011 | 349 | 0.200 |
Why?
|
| Frail Elderly | 2 | 2019 | 68 | 0.190 |
Why?
|
| Thigh | 2 | 2019 | 42 | 0.190 |
Why?
|
| Respiratory Function Tests | 2 | 2018 | 100 | 0.190 |
Why?
|
| Nutritional Sciences | 1 | 2020 | 9 | 0.180 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2020 | 19 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2018 | 835 | 0.180 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2019 | 10 | 0.170 |
Why?
|
| Soft Tissue Injuries | 1 | 2019 | 20 | 0.170 |
Why?
|
| Risk Assessment | 5 | 2018 | 1426 | 0.170 |
Why?
|
| Chronic Disease | 2 | 2012 | 406 | 0.170 |
Why?
|
| Chi-Square Distribution | 4 | 2012 | 297 | 0.170 |
Why?
|
| Dietary Fats | 3 | 2014 | 110 | 0.160 |
Why?
|
| Vitamin K | 1 | 2018 | 9 | 0.160 |
Why?
|
| Random Allocation | 1 | 2019 | 226 | 0.160 |
Why?
|
| Age Factors | 5 | 2018 | 1188 | 0.160 |
Why?
|
| Disability Evaluation | 3 | 2019 | 240 | 0.160 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 301 | 0.160 |
Why?
|
| Bone and Bones | 1 | 2019 | 94 | 0.160 |
Why?
|
| Lung Diseases | 1 | 2018 | 46 | 0.160 |
Why?
|
| Vesicular Transport Proteins | 1 | 2018 | 10 | 0.150 |
Why?
|
| Seafood | 1 | 2017 | 11 | 0.150 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 29 | 0.150 |
Why?
|
| Docosahexaenoic Acids | 1 | 2017 | 21 | 0.150 |
Why?
|
| Inflammation | 2 | 2012 | 530 | 0.150 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 167 | 0.150 |
Why?
|
| Appetite | 1 | 2017 | 22 | 0.150 |
Why?
|
| Osteoarthritis, Knee | 1 | 2018 | 90 | 0.150 |
Why?
|
| Genome, Human | 2 | 2018 | 132 | 0.150 |
Why?
|
| Heart | 1 | 2018 | 177 | 0.140 |
Why?
|
| Urinary Incontinence | 1 | 2017 | 47 | 0.140 |
Why?
|
| Absorptiometry, Photon | 4 | 2014 | 143 | 0.140 |
Why?
|
| Lower Extremity | 1 | 2018 | 100 | 0.140 |
Why?
|
| Genetics, Population | 1 | 2017 | 32 | 0.140 |
Why?
|
| Walking | 3 | 2013 | 209 | 0.140 |
Why?
|
| Dietary Carbohydrates | 2 | 2014 | 22 | 0.140 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2014 | 15 | 0.140 |
Why?
|
| Prevalence | 4 | 2018 | 981 | 0.140 |
Why?
|
| Exercise Therapy | 2 | 2019 | 270 | 0.140 |
Why?
|
| Membrane Proteins | 2 | 2018 | 256 | 0.140 |
Why?
|
| Odds Ratio | 4 | 2017 | 472 | 0.130 |
Why?
|
| Meat Products | 1 | 2015 | 3 | 0.130 |
Why?
|
| Hyperinsulinism | 1 | 2015 | 13 | 0.130 |
Why?
|
| Health Behavior | 3 | 2014 | 232 | 0.130 |
Why?
|
| Time Factors | 5 | 2015 | 2149 | 0.130 |
Why?
|
| Hip Fractures | 2 | 2012 | 31 | 0.130 |
Why?
|
| Phenotype | 5 | 2015 | 632 | 0.130 |
Why?
|
| Stroke Volume | 1 | 2018 | 348 | 0.130 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 53 | 0.130 |
Why?
|
| Epistasis, Genetic | 1 | 2015 | 44 | 0.130 |
Why?
|
| Hyperglycemia | 1 | 2015 | 84 | 0.120 |
Why?
|
| Single-Blind Method | 1 | 2015 | 203 | 0.120 |
Why?
|
| Coffea | 1 | 2014 | 1 | 0.120 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2014 | 9 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2015 | 293 | 0.120 |
Why?
|
| Antidepressive Agents | 1 | 2014 | 74 | 0.120 |
Why?
|
| Hearing Loss | 1 | 2014 | 26 | 0.120 |
Why?
|
| Genetic Variation | 2 | 2012 | 244 | 0.120 |
Why?
|
| Health Surveys | 2 | 2011 | 196 | 0.120 |
Why?
|
| Apolipoprotein E4 | 1 | 2014 | 63 | 0.120 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2013 | 11 | 0.120 |
Why?
|
| Fasting | 2 | 2012 | 95 | 0.110 |
Why?
|
| Muscle Weakness | 1 | 2014 | 37 | 0.110 |
Why?
|
| Adiposity | 2 | 2012 | 198 | 0.110 |
Why?
|
| Health Education | 1 | 2014 | 157 | 0.110 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 876 | 0.110 |
Why?
|
| Nutrition Surveys | 5 | 2013 | 148 | 0.110 |
Why?
|
| Homozygote | 2 | 2010 | 58 | 0.110 |
Why?
|
| PPAR gamma | 2 | 2011 | 46 | 0.110 |
Why?
|
| Calcium, Dietary | 1 | 2013 | 23 | 0.110 |
Why?
|
| Trace Elements | 1 | 2013 | 7 | 0.110 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 17 | 0.110 |
Why?
|
| Lipoprotein Lipase | 1 | 2012 | 14 | 0.110 |
Why?
|
| Magnesium | 1 | 2013 | 30 | 0.110 |
Why?
|
| Receptors, Calcitriol | 1 | 2012 | 9 | 0.110 |
Why?
|
| Hyperparathyroidism | 1 | 2012 | 9 | 0.110 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2012 | 5 | 0.100 |
Why?
|
| Seasons | 4 | 2015 | 88 | 0.100 |
Why?
|
| Gene Frequency | 3 | 2018 | 220 | 0.100 |
Why?
|
| Insulin Resistance | 1 | 2015 | 462 | 0.100 |
Why?
|
| Homeostasis | 1 | 2012 | 132 | 0.100 |
Why?
|
| Linkage Disequilibrium | 4 | 2013 | 185 | 0.100 |
Why?
|
| Urban Population | 1 | 2012 | 89 | 0.100 |
Why?
|
| Heart Failure | 1 | 2018 | 639 | 0.100 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2012 | 51 | 0.100 |
Why?
|
| Knee | 1 | 2011 | 33 | 0.100 |
Why?
|
| Socioeconomic Factors | 2 | 2014 | 423 | 0.100 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 24 | 0.100 |
Why?
|
| Lipids | 1 | 2012 | 232 | 0.100 |
Why?
|
| Zinc | 1 | 2011 | 32 | 0.100 |
Why?
|
| Calcium | 1 | 2013 | 307 | 0.090 |
Why?
|
| Pain Measurement | 1 | 2012 | 350 | 0.090 |
Why?
|
| Reference Values | 1 | 2011 | 246 | 0.090 |
Why?
|
| Anthropometry | 2 | 2014 | 83 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 105 | 0.090 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 47 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2018 | 898 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2012 | 180 | 0.090 |
Why?
|
| Fractures, Bone | 1 | 2012 | 148 | 0.090 |
Why?
|
| Quality of Life | 2 | 2019 | 946 | 0.090 |
Why?
|
| Body Fat Distribution | 1 | 2010 | 34 | 0.090 |
Why?
|
| Resistance Training | 1 | 2011 | 82 | 0.090 |
Why?
|
| Europe | 3 | 2017 | 82 | 0.090 |
Why?
|
| Hypertension | 2 | 2014 | 959 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 104 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 181 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2010 | 147 | 0.080 |
Why?
|
| Physical Endurance | 1 | 2008 | 36 | 0.080 |
Why?
|
| Age Distribution | 1 | 2009 | 206 | 0.080 |
Why?
|
| Health Status Disparities | 1 | 2009 | 122 | 0.080 |
Why?
|
| Oxygen Consumption | 2 | 2019 | 154 | 0.080 |
Why?
|
| Arteriosclerosis | 2 | 2005 | 123 | 0.070 |
Why?
|
| Logistic Models | 2 | 2011 | 781 | 0.070 |
Why?
|
| Hospitalization | 1 | 2010 | 470 | 0.070 |
Why?
|
| Patient Selection | 1 | 2008 | 276 | 0.070 |
Why?
|
| Exercise Test | 2 | 2019 | 227 | 0.070 |
Why?
|
| Sex Distribution | 1 | 2007 | 191 | 0.070 |
Why?
|
| Atherosclerosis | 2 | 2013 | 766 | 0.070 |
Why?
|
| Forced Expiratory Volume | 2 | 2018 | 87 | 0.070 |
Why?
|
| Fibroblast Growth Factors | 2 | 2018 | 35 | 0.070 |
Why?
|
| Prognosis | 3 | 2018 | 1497 | 0.070 |
Why?
|
| Regression Analysis | 2 | 2018 | 293 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 1128 | 0.060 |
Why?
|
| Neuropsychological Tests | 2 | 2016 | 371 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 684 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 67 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2008 | 3509 | 0.060 |
Why?
|
| Quantitative Trait Loci | 2 | 2013 | 140 | 0.050 |
Why?
|
| Dietary Fiber | 1 | 2002 | 19 | 0.050 |
Why?
|
| Risk | 2 | 2014 | 321 | 0.050 |
Why?
|
| Cause of Death | 2 | 2012 | 236 | 0.050 |
Why?
|
| Biomass | 1 | 2020 | 3 | 0.050 |
Why?
|
| Abdominal Fat | 2 | 2011 | 50 | 0.040 |
Why?
|
| Subcutaneous Fat | 2 | 2011 | 47 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2011 | 125 | 0.040 |
Why?
|
| Smoking | 2 | 2018 | 497 | 0.040 |
Why?
|
| Muscle Development | 1 | 2020 | 49 | 0.040 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2019 | 8 | 0.040 |
Why?
|
| Muscles | 1 | 2020 | 62 | 0.040 |
Why?
|
| Maryland | 1 | 2019 | 28 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 633 | 0.040 |
Why?
|
| Residence Characteristics | 2 | 2012 | 191 | 0.040 |
Why?
|
| Tomography | 1 | 2019 | 4 | 0.040 |
Why?
|
| Hip | 1 | 2019 | 15 | 0.040 |
Why?
|
| Fatigue | 1 | 2019 | 85 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2011 | 483 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 2636 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 20 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2018 | 40 | 0.040 |
Why?
|
| Weight Gain | 1 | 2019 | 117 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2018 | 9 | 0.040 |
Why?
|
| Geriatrics | 1 | 2019 | 85 | 0.040 |
Why?
|
| Femur | 1 | 2019 | 74 | 0.040 |
Why?
|
| Lumbar Vertebrae | 1 | 2019 | 101 | 0.040 |
Why?
|
| Amidohydrolases | 1 | 2018 | 8 | 0.040 |
Why?
|
| Health Services for the Aged | 1 | 2018 | 25 | 0.040 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2017 | 1 | 0.040 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 125 | 0.040 |
Why?
|
| Hispanic Americans | 2 | 2018 | 940 | 0.040 |
Why?
|
| Actins | 1 | 2017 | 51 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 48 | 0.040 |
Why?
|
| Genomics | 1 | 2018 | 85 | 0.040 |
Why?
|
| Posture | 1 | 2017 | 55 | 0.040 |
Why?
|
| Postural Balance | 1 | 2017 | 182 | 0.030 |
Why?
|
| Publication Bias | 1 | 2015 | 8 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 146 | 0.030 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2015 | 9 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 2 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 881 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 37 | 0.030 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2014 | 108 | 0.030 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2014 | 1 | 0.030 |
Why?
|
| Georgia | 1 | 2014 | 14 | 0.030 |
Why?
|
| Calcifediol | 1 | 2014 | 7 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 160 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2013 | 27 | 0.030 |
Why?
|
| Metagenomics | 1 | 2013 | 3 | 0.030 |
Why?
|
| North America | 1 | 2013 | 32 | 0.030 |
Why?
|
| TRPM Cation Channels | 1 | 2013 | 4 | 0.030 |
Why?
|
| Steroid Hydroxylases | 1 | 2012 | 2 | 0.030 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2012 | 5 | 0.030 |
Why?
|
| Medicare | 1 | 2014 | 206 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2013 | 141 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 43 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 582 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2012 | 124 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 70 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 193 | 0.030 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 177 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 105 | 0.030 |
Why?
|
| Triglycerides | 1 | 2012 | 230 | 0.020 |
Why?
|
| Distance Perception | 1 | 2011 | 3 | 0.020 |
Why?
|
| Judgment | 1 | 2011 | 11 | 0.020 |
Why?
|
| Intention | 1 | 2011 | 28 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 217 | 0.020 |
Why?
|
| Child | 1 | 2018 | 2438 | 0.020 |
Why?
|
| Continental Population Groups | 1 | 2013 | 237 | 0.020 |
Why?
|
| Arm | 1 | 2011 | 35 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 463 | 0.020 |
Why?
|
| Choristoma | 1 | 2011 | 17 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 218 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 99 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2010 | 10 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2010 | 24 | 0.020 |
Why?
|
| Immunoassay | 1 | 2010 | 16 | 0.020 |
Why?
|
| International Cooperation | 1 | 2010 | 28 | 0.020 |
Why?
|
| Canada | 1 | 2010 | 56 | 0.020 |
Why?
|
| Heterozygote | 1 | 2010 | 59 | 0.020 |
Why?
|
| Adipokines | 1 | 2010 | 16 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2010 | 31 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 495 | 0.020 |
Why?
|
| Self Disclosure | 1 | 2010 | 22 | 0.020 |
Why?
|
| Water | 1 | 2010 | 56 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2010 | 60 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 3539 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2009 | 90 | 0.020 |
Why?
|
| Baltimore | 1 | 2009 | 50 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 184 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 475 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 560 | 0.020 |
Why?
|
| Postmenopause | 1 | 2008 | 430 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 918 | 0.020 |
Why?
|
| Neoplasms | 1 | 2012 | 726 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2007 | 249 | 0.020 |
Why?
|
| North Carolina | 1 | 2002 | 1514 | 0.010 |
Why?
|